Torrent Pharmaceuticals Limited (BOM:500420)
4,464.50
-44.45 (-0.99%)
At close: Jun 16, 2026
Torrent Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Torrent Pharmaceuticals had annual revenue of 139.80B INR with 21.39% growth. Torrent Pharmaceuticals had revenue of 41.97B in the quarter ending March 31, 2026, with 41.83% growth.
Revenue
139.80B
Revenue Growth
+21.39%
P/S Ratio
10.81
Revenue / Employee
7.66M
Employees
18,258
Market Cap
1.51T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 139.80B | 24.64B | 21.39% |
| Mar 31, 2025 | 115.16B | 7.88B | 7.35% |
| Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
| Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
| Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 335.93B |
| Lupin | 279.58B |
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
| Viyash Scientific | 34.20B |
Torrent Pharmaceuticals News
- 6 days ago - Nomura on Pharma May 2026: Torrent leads semaglutide with 19% market share, Sun gains; Alkem and Dr Reddy's lag market - Business Upturn
- 13 days ago - Torrent Pharmaceuticals announces 53rd AGM via video conference on 23rd June 2026 - Business Upturn
- 15 days ago - Torrent Pharmaceuticals releases business responsibility and sustainability report for FY 2025-26 - Business Upturn
- 23 days ago - Torrent Pharmaceuticals shares hit 52-week today despite Q4 profit decline; revenue surges 42% - Business Upturn
- 23 days ago - Here’s why Torrent Pharma shares are up 4% today - Business Upturn
- 23 days ago - Top stocks for trade today, May 25: Hindalco Industries, Torrent Pharma, Divi’s Lab, Eicher Motors, NTPC Green and more - Business Upturn
- 25 days ago - Torrent Pharmaceuticals Transcript: Q4 25/26 - Transcripts
- 25 days ago - Torrent Pharmaceuticals Slides: Q4 2026 - Filings